1. Home
  2. ARDX vs CXM Comparison

ARDX vs CXM Comparison

Compare ARDX & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.97

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Sprinklr Inc.

CXM

Sprinklr Inc.

HOLD

Current Price

$5.47

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
CXM
Founded
2007
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
ARDX
CXM
Price
$6.97
$5.47
Analyst Decision
Strong Buy
Hold
Analyst Count
7
8
Target Price
$15.14
$8.28
AVG Volume (30 Days)
3.8M
4.6M
Earning Date
04-30-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.09
Revenue
$2,607,000.00
$857,200,000.00
Revenue This Year
$37.75
$2.52
Revenue Next Year
$34.24
$4.94
P/E Ratio
N/A
$58.06
Revenue Growth
N/A
7.64
52 Week Low
$3.54
$4.72
52 Week High
$8.40
$9.40

Technical Indicators

Market Signals
Indicator
ARDX
CXM
Relative Strength Index (RSI) 62.75 52.59
Support Level $6.83 $5.19
Resistance Level $8.23 $6.16
Average True Range (ATR) 0.36 0.23
MACD 0.11 0.06
Stochastic Oscillator 69.88 88.35

Price Performance

Historical Comparison
ARDX
CXM

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

Share on Social Networks: